Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022
NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that Mr. Darren Lui, CEO and Executive Director of Aptorum Group will present both in-person and virtually at the H.C. Wainwright … [Read more…]
